Episode 3.3 When should we use new treatments? Jada And cfDNA episode artwork

EPISODE · Feb 10, 2022 · 55 MIN

Episode 3.3 When should we use new treatments? Jada And cfDNA

from Thinking About Ob/Gyn

In this episode we discuss the new Jada postpartum hemorrhage device. More importantly, we discuss the process for choosing to utilize new interventions in clinical practice. Then we discuss a recent New York Times article detailing the problem of false positives in the noninvasive prenatal screening tests. Follow us on Instagram @thinkingaboutobgyn.

Episode metadata supplied by the publisher feed · Published Feb 10, 2022

Embed this episode

NOW PLAYING

Episode 3.3 When should we use new treatments? Jada And cfDNA

0:00 55:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Thinking About Ob/Gyn?

This episode is 55 minutes long.

When was this Thinking About Ob/Gyn episode published?

This episode was published on February 10, 2022.

Can I download this Thinking About Ob/Gyn episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!